20/20 Biolabs, Inc. - AIDX

Sector: Healthcare · Industry: Medical Devices
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$292K
QoQ value delta ($000)
$0 (0.0%)
Implied price effect (QoQ)
+0.02%
Shares
Total shares
540,520
QoQ shares delta
-100 (-0.02%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (AIDX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Cresset Asset Management, LLC 131 240,122 0.0%
HRT FINANCIAL LP 49 89,273 0.0%
VANGUARD FIDUCIARY TRUST CO 28 52,087 0.0%
GEODE CAPITAL MANAGEMENT, LLC 27 49,141 0.0%
Atlantic Union Bankshares Corp 19 35,099 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 13 24,530 0.0%
CITADEL ADVISORS LLC 12 23,205 0.0%
BANK OF AMERICA CORP /DE/ 7 13,024 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 5 10,014 0.0%
MCDONALD PARTNERS LLC 1 2,800 0.0%
MORGAN STANLEY 0 283 0.0%
SIGNATUREFD, LLC 0 767 0.0%
Allworth Financial LP 0 172 0.0%
UBS Group AG 0 3 0.0%